Development of solid phase competitive enzyme-linked immunosorbent assay to detect foot-and-mouth disease virus A serotype specific antibodies based on immunoglobulin Y antibody

Document Type : Original Article

Authors

1 Department of Microbiology, Karaj Branch, Islamic Azad University, Karaj, Iran

2 Razi Vaccine and Serum Research Institute (RVSRI), Agricultural Research, Education, and Extension Organization (AREEO), Karaj, Iran

Abstract
The aim of this study was to using purified chicken antibody (IgY) for developing solid phase competitive (SPC) enzyme-linked immunosorbent assay (ELISA) to detect the foot-and-mouth disease virus (FMDV) A serotype. After immunization of chickens, polyclonal immunoglobulin (IgY) antibodies were extracted and purified from egg yolk and yield was about 5.00 mg mL-1 of yolk as well as near 0.40 mg mL-1 of specific IgY antibody against FMDV serotype A. Also, optimized sucrose density gradient method produced 228 µg mL-1 whole virus which is much higher than that of the conventional method of sucrose density gradient method. The optimum concentration of purified capture IgY and bind type A antigen were 0.50 µg and 0.10 µg per well, respectively. The OD values < 0.70 were considered positive, and values ≥ 0.70 were negative for in-house kit base on standard controls. Statistical analysis base on 80 serum samples showed the 96.66% sensitivity, 100% specificity, 100% positive predictive value, 90.90% negative predictive value, 97.50% accuracy, and 98.33% reliability for serum samples for two commercial and in-house kits. The SPCE developed based on IgY antibody is a suitable alternative for the detection of antibodies after vaccination against type A FMDV with high sensitivity and specificity. The present research demonstrated the possibility of commercial development of the SPCE kit using IgY antibodies for the detection of FMDV antibodies in serum samples with adequate sensitivity and accuracy.

Keywords

Subjects


  1. Jamal SM, Belsham GJ. Foot-and-mouth disease: past, present and future: Vet Res 2013; 44(1): 116. doi: 10.1186/1297-9716-44-116.
  2. Jamal SM, Ferrari G, Hussain M, et al. Detection and genetic characterization of foot‐and‐mouth disease viruses in samples from clinically healthy animals in endemic settings. Transbound Emerg Dis 2012; 59(5): 429-440.
  3. Sáiz M, Núñez JI, Jimenez-Clavero MA, et al. Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect 2002; 4(11): 1183-1192.
  4. Alexandersen S, Zhang Z, Donaldson AI, et al. The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol 2003; 129(1): 1-36.
  5. Stear MJ. OIE manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds and bees). 5th Volumes 1 & 2. World Organization for Animal Health 2004. ISBN 92 9044 622 6. € 140. Parasitology 2005; 130(6): 727-727.
  6. Ma LN, Zhang J, Chen HT, et al. An overview on ELISA techniques for FMD. Virol J 2011; 8: 419. doi:10.1186/ 1743-422X-8-4197.
  7. Mackay DK, Bulut AN, Rendle T, et al. A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus. J Virol Methods 2001; 97(1-2): 33-48.
  8. Basagoudanavar SH, Hosamani M, Tamil Selvan RP, et al. Development of a liquid-phase blocking ELISA based on foot-and-mouth disease virus empty capsid antigen for sero monitoring vaccinated animals. Arch Virol 2013; 158(5): 993-1001.
  9. Chénard G, Miedema K, Moonen P, et al. A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology. J Virol Methods 2003; 107(1): 89-98.
  10. Feng X, Ma JW, Sun SQ, et al. Quantitative detection of the foot-and-mouth disease virus serotype O 146S antigen for vaccine production using a double-antibody sandwich ELISA and nonlinear standard curves. PLoS One 2016; 11(3): e0149569. doi: 10.1371/journal. pone.0149569.
  11. Paiba GA, Anderson J, Paton DJ, et al. Validation of a foot-and-mouth disease antibody screening solid-phase competition ELISA (SPCE). J Virol Methods 2004; 115(2): 145-158.
  12. Ayele G, Getachew B, Bari FD, et al. Combined adjuvant formulations enhanced an immune response of trivalent foot-and-mouth disease vaccine in cattle. Vet Med (Akucl) 2023; 14: 47-62.
  13. Polson A, Coetzer T, Kruger J, et al. Improvements in the isolation of IgY from the yolks of eggs laid by immunized Immunol Invest 1985; 14(4): 323-327.
  14. Ilbeigi K, Bokaie S, Aghasharif S, et al. Risk factors for recurrence of FMD outbreaks in Iran: a case-control study in a highly endemic area. BMC Vet Res 2018;14(1): 253. doi: 10.1186/s12917-018-1580-3.
  15. Bahnemann HG. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. Arch Virol 1975; 47(1): 47-56.
  16. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol 1938; 27(3): 493-497.
  17. Li P, Bai X, Cao Y, et al. Expression and stability of foreign epitopes introduced into 3A nonstructural protein of foot-and-mouth disease PLoS One 2012; 7(7): e41486. doi: 10.1371/journal.pone.0041486.
  18. Barteling SJ, Meloen RH. A simple method for the quantification of 140S particles of foot-and-mouth disease virus (FMDV). Arch Gesamte Virusforsch 1974; 45(4): 362-364.
  19. Tompkins ER, Mayer SW. Ion exchange as a separations method; equilibrium studies of the reactions of rare earth complexes with synthetic ion exchange resins. J Am Chem Soc 1947; 69(11): 2859-2865.
  20. Ivani Z, Ranjbar MM, Hemati B, et al. Evaluation of specific chicken IgY antibody value developing diagnostic capture antibody ELISA kit against Foot-and-Mouth disease. Arch Razi Inst 2024; 79(1): 201-210.
  21. Sørensen KJ, Madsen KG, Madsen ES, et al. Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus. Arch Virol 1998; 143(8): 1461-1476.
  22. Longjam N, Deb R, Sarmah AK, et al. A brief review on diagnosis of foot-and-mouth disease of livestock: conventional to molecular tools. Vet Med Int 2011; 2011: 905768. doi: 10.4061/2011/905768.
  23. Cao Y, Li K, Xing X, et al. Development and validation of a competitive ELISA based on bovine monoclonal antibodies for the detection of neutralizing antibodies against foot-and-mouth disease virus serotype A. J Clin Microbiol 2022; 60(4): e02142-21. doi: 10.1128/ jcm.02142-21.
  24. Araújo JP, Montassier HJ, Pinto AA. Liquid-phase blocking sandwich enzyme-linked immunosorbent assay for detection of antibodies against foot-and-mouth disease virus in water buffalo sera. Am J Vet Res 1996; 57(6): 840-843.
  25. Li Y, Swabey KG, Gibson D, et al. Evaluation of the solid phase competition ELISA for detecting antibodies against the six foot-and-mouth disease virus non-O serotypes. J Virol Methods 2012; 183(2): 125-131.
  26. Abubakar M, Manzoor S, Ahmed A. Interplay of foot-and-mouth disease virus with cell‐mediated and humoral immunity of host. Rev Med Virol 2018; 28(2): doi: 10.1002/rmv.1966.
  27. Gobiye M, Fosgate GT, Heath L, et al. Preliminary validation of a single-spot version of a solid-phase competition ELISA for the detection of southern African territories foot-and-mouth disease serotype exposure in goats. Small Rumin Res 2023; 224: 106982. doi: 10.1016/j.smallrumres.2023.106982.
  28. Ran X, Yang Z, Bai M, et al. Development and validation of a competitive ELISA based on bacterium-original virus-like particles of serotype O foot-and-mouth disease virus for detecting serum antibodies. Appl Microbiol Biotechnol 2019; 103(7): 3015-3024.
  29. Şevik M, Öztürk FF. Comparative evaluation of liquid-phase blocking ELISA and solid-phase competition ELISA methods for the detection of antibodies to the structural proteins of foot-and-mouth disease types O and A viruses. Turk J Vet Anim Sci 2013; 37(5): 523-528.
  30. Zhang Y, Yan H, Yao Y, et al. Development and validation of a solid-phase competition ELISA based on virus-like particles of foot-and-mouth disease virus serotype A for antibody detection. Arch Virol 2020; 165(7): 1641-1646.
Volume 16, Issue 5
May 2025
Pages 285-292

  • Receive Date 02 April 2024
  • Revise Date 24 August 2024
  • Accept Date 05 November 2024